Throughout the year Lake Whillans, with the help of MedCity News, has explored two key issues for healthcare investors and entrepreneurs: trust and reliability. We’ve helped bring to light some harrowing war stories of partnerships gone bad. We’ve also asked healthcare leaders in the trenches about the best ways to operate in the modern healthcare […]
Scientists suspect there’s a connection between many common neurodegenerative diseases and malfunctioning lysosomes, or processing centers in human cells that break down proteins and eliminate debris. Now a new company called Lysosomal Therapeutics is tapping into the relationship between the two to discover and develop new treatments for rare diseases and common neurodegenerative diseases, starting […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Corporate venture capital may be what fills in the large gaps VC has left behind, with CVC deals about 60 percent larger than VC deals on the whole. Healthcare corporate venture capital deals are up nearly 40 percent compared to Q1 and funding is up 34 percent, according to a report from CB Insights. There were […]
A recently formed, Indianapolis-based pharmaceutical company is in the middle of a $15 million equity offering, according to a Securities and Exchange Commission filing made last week. Esanex Inc.’s principal place of business is listed as the office of Lilly Ventures, the venture capital firm that spun out of Eli Lilly and Co. in 2009 […]
The move is a trend that's happened to several pharmaceutical-based funds, which used to pick its start ups to secure product rights. Now, though, those dollars are used to keep up on new technologies and make money. Lilly Ventures in its old form couldn't take profits from investments because Lilly's compensation policies did not permit it.